Showing: 1 - 2 of 2 RESULTS

Synopsys to Enable New Levels of Insight into SoC Designs and Systems with Industry’s First Silicon Lifecycle Management Platform

MOUNTAIN VIEW, Calif., Oct. 12, 2020 /PRNewswire/ —

Highlights:

  • Increasing chip and system complexity, coupled with growing performance and reliability requirements, are driving the need for ongoing post-silicon analysis, maintenance and optimization
  • The Synopsys SLM platform closes the silicon loop through the analysis of on-chip monitor and sensor data to optimize all phases of the silicon lifecycle
  • Potential financial benefits from improvements in performance, reliability and functional safety in industries such as data centers and automotive are measured in the billions of dollars
  • New expanded TAM opportunity builds on Synopsys’ leadership in chip and system design, verification, test, design IP and long-standing links to manufacturing

Synopsys, Inc. (Nasdaq: SNPS) today, in a move that expands its industry leadership throughout the design lifecycle, unveiled its Silicon Lifecycle Management (SLM) platform, the industry’s first data-analytics-driven approach to optimizing SoCs from the design phase through to end-user deployment. The SLM platform,

Read More

Silicon Therapeutics Unveils Refreshed Corporate Branding and Redesigned Website

Silicon Therapeutics, a privately-held, fully integrated drug design, discovery and development company focused on small molecule therapeutics, today introduced an updated corporate website, which reflects the company’s mission, research approach and core values.

The new Silicon Therapeutics site more accurately tells the company’s story and clearly highlights the company’s mission to improve the lives of patients by creating novel, disease-modifying medicines for challenging targets, using its proprietary, quantum physics-driven discovery engine.

“We worked to develop a meaningful brand architecture and visual identity that embodies the company’s strategic approach and core ethos,” said Lanny Sun, co-founder and chief executive officer. “This project has been part of our strategy to more fully engage with investors, potential partners, scientists and future employees while highlighting our differentiated approach and the opportunities that our platform presents for the company.”

The new site is expanded with deeper scientific content and the layout is structured for ease

Read More